Erick Avelar, MD, FACC

Erick Avelar, MD, FACC

Erick Avelar, MD, FACC

Associate Professor of Medicine

OHVC; St Mary’s Medical Group

706-389-3440

Education

2006-2008 – Massachusetts General Hospital, Boston, MA

Fellowship – Cardiology: Advanced Imaging Fellowship: level III Echo, MRI, CT

2002-2006 – The University of Utah School of Medicine, Salt Lake City, UT

Fellowship – Cardiology

2004-2006 – The University of Utah School of Medicine, Salt Lake City, UT

Master of Clinical Investigation – K30/NIH program

2000–2002 – Good Samaritan Hospital/UC, Cincinnati, OH

Residency – Internal Medicine

1999–2000 – Good Samaritan Hospital/UC, Cincinnati, OH

Internship-Internal Medicine

1998–1999 – University of Michigan, Ann Arbor, MI

Postdoctoral Fellow – Cardiology  Research

1996–1998 – NEMC-Tufts University, Boston, MA

Postdoctoral Fellow – Cardiology  Research

1994-1996 – Oswaldo Cruz University Hospital, Recife, Brazil

Internship and Residency- Internal Medicine

1993-1994 – Army General  Hospital, Recife, Brazil

Internship- Critical Care

1986-1993 – Federal University, Recife, Brazil

Medical School 

1983-1986 – Agnes Erskine-Recife-Brazil

Undergraduate / college (major: health science)

Selected Publications

Avelar, Erick; et al. (Accepted for publication- Journal of Thoracic Imaging 2017). Effect of Adjuvant Chemotherapy on Left Ventricular Remodeling in Newly Diagnosed Primary Breast Cancer Women:  A Pilot Prospective Longitudinal Cardiac Magnetic Resonance Imaging Study.

Avelar, Erick; et al. (June 2017).  Role of cardiac Imaging in cardio-oncology. Current Treatment Options in Cardiovascular Medicine.

Inyangetor D, Czarnecki C, Sands MJ, Avelar E. Left ventricular noncompaction associated with multiple coronary cameral fistulae. Tex Heart Inst J. 2012; 39(2): 294-295.

Macatangay C, Marfatia R, Kaloudis E, Avelar E. Apical hypertrophic cardiomyopathy associated with chronic hypertension: diagnostic and management implications. Connecticut Medicine. 2012; 76(4):147-150.

Kumar S, Marfatia R, Tannenbaum S, Yang C, Avelar E. Doxorubicin-induced cardiotoxicity manifesting 17 years after treatment. Tex Heart Inst J.  2012; 39(3):424-7.

Alluri N, Kumar S, Marfatia R, Patil P, Ryan J, Avelar E. Aortic valve perforation diagnosed with use of 3-dimensional transesophageal echocardiography. Tex Heart Inst J. 2012;39 (4):590-1.

Grant Support

NIH/Cornell University, 2015-2017

Computed TomogRaphic Evaluation of Atherosclerotic DetermiNants of Myocardial IsChEmia(CREDENCE)

Site PI at St Mary’s hospital.

NIH/Duke University, 2010-2015

PROspective Mulitcenter Imaging Study for Evaluation of Chest Pain (PROMISE)

Site PI at UCONN

Connecticut Breast Health Initiative, 2012-2013

Early Detection of Cardiotoxicity by advanced Cardio-Imaging and a Novel Biomarker in Breast Cancer Patients undergoing chemotherapy

Connecticut Breast Health Initiative, 2010-2012

Early Detection of Cardiotoxicity by advanced Cardio-Imaging and a Novel Biomarker in Breast Cancer Patients undergoing chemotherapy

McPhee Foundation, 201o-2011

Early Detection of Cardiotoxicity by advanced Cardio-Imaging and a Novel Biomarker in Breast Cancer Patients undergoing chemotherapy

For more information about attending the Medical College of Georgia at the Medical Partnership campus

Learn More Apply Now